HA
ASTX

Havens Advisors’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Havens Advisors’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-290,000
Closed -$2.46M – 59
2013
Q3 		$2.46M Buy
+290,000
New +$1.84M 1.37% 29

Havens Advisors's ASTX Position: Q4 2013 in Review

Havens Advisors sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 290,000 shares — an estimated $2.46M sold.

Havens Advisors first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $2.46M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Havens Advisors reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Havens Advisors sold 290,000 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $2.46M.
  • Havens Advisors first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
  • Havens Advisors's ASTEX PHARMACEUTICALS, INC COM position peaked at $2.46M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Havens Advisors's 13F filing for Q4 2013, filed 29 Jan 2014.